From todays press.
''The main loser among the top 200 this morning is CSL, which is down about 5 per cent after an Alzheimer's therapy by competitor Baxter failed in late stage trial.
This is seen as a blow for CSL as both the Australian company and Baxter stood to benefit from the potential use of immunoglobulin treatments in Alzheimer's patients.''
From todays press.''The main loser among the top 200 this...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CSL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$293.00 |
Change
-0.870(0.30%) |
Mkt cap ! $141.5B | |||
| Open | High | Low | Value | Volume |
| $295.00 | $295.48 | $292.18 | $173.0M | 589.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 862 | $292.88 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $293.08 | 502 | 2 |
View Market Depth
| Last trade - 16.10pm 19/06/2024 (20 minute delay) ? |
| CSL (ASX) Chart |